Healthcare provider profile · identity verified

Steven P Seres, MD

Internal Medicine · BEACHWOOD, OH · NPI 1528036720

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	544	228
Amlodipine Besylate	Amlodipine Besylate	333	135
Lisinopril	Lisinopril	331	126
Levothyroxine Sodium	Levothyroxine Sodium	238	91
Rosuvastatin Calcium	Rosuvastatin Calcium	230	104
Losartan Potassium	Losartan Potassium	215	94
Metoprolol Succinate	Metoprolol Succinate	200	88
Omeprazole	Omeprazole	170	76
Gabapentin	Gabapentin	126	52
Tamsulosin Hcl	Tamsulosin Hcl	125	52
Trazodone Hcl	Trazodone Hcl	121	52
Hydrochlorothiazide	Hydrochlorothiazide	109	45
Simvastatin	Simvastatin	97	38
Allopurinol	Allopurinol	91	36
Jardiance	Empagliflozin	87	26
Pantoprazole Sodium	Pantoprazole Sodium	87	40
Duloxetine Hcl	Duloxetine Hcl	77	29
Metformin Hcl	Metformin Hcl	73	32
Ozempic	Semaglutide	67	13
Spironolactone	Spironolactone	67	25
Sertraline Hcl	Sertraline Hcl	66	23
Finasteride	Finasteride	65	22
Eliquis	Apixaban	63	19
Escitalopram Oxalate	Escitalopram Oxalate	62	24
Albuterol Sulfate Hfa	Albuterol Sulfate	61	25
Metformin Hcl Er	Metformin Hcl	54	30
Synthroid	Levothyroxine Sodium	54	20
Pravastatin Sodium	Pravastatin Sodium	51	19
Carvedilol	Carvedilol	50	18
Metoprolol Tartrate	Metoprolol Tartrate	47	18
Citalopram Hbr	Citalopram Hydrobromide	44	16
Meloxicam	Meloxicam	42	24
Zolpidem Tartrate	Zolpidem Tartrate	41	14
Bupropion Xl	Bupropion Hcl	38	16
Tramadol Hcl	Tramadol Hcl	38	18
Glipizide Er	Glipizide	36	16
Venlafaxine Hcl Er	Venlafaxine Hcl	36	13
Alprazolam	Alprazolam	35	12
Pregabalin	Pregabalin	35	suppressed
Clopidogrel	Clopidogrel Bisulfate	34	11
Famotidine	Famotidine	32	suppressed
Warfarin Sodium	Warfarin Sodium	32	12
Torsemide	Torsemide	31	suppressed
Fluticasone Propionate	Fluticasone Propionate	29	20
Januvia	Sitagliptin Phosphate	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Acyclovir	Acyclovir	27	suppressed
Ezetimibe	Ezetimibe	27	12
Mirtazapine	Mirtazapine	26	12
Potassium Chloride	Potassium Chloride	26	12
Prednisone	Prednisone	26	24
Farxiga	Dapagliflozin Propanediol	25	suppressed
Furosemide	Furosemide	24	14
Montelukast Sodium	Montelukast Sodium	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	11
Methocarbamol	Methocarbamol	20	suppressed
Valsartan	Valsartan	20	suppressed
Glipizide	Glipizide	19	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Clonazepam	Clonazepam	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Atenolol	Atenolol	12	suppressed
Levoxyl	Levothyroxine Sodium	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Single Use Swab	Alcohol Antiseptic Pads	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Celecoxib	Celecoxib	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error